Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Micronized Progesterone for Perimenopausal Menstrual Flow
NCT02779582Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of progesterone in perimenopause, dysmenorrhea, sponsored by University of British Columbia. Started Jun 2015; status: completed.
02
Drugs
progesterone
03
Conditions
perimenopausedysmenorrhea
Beyond the preview
Go deeper on NCT02779582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02779582.